Publications by Statistical Genetics and Epidemiology Our research spans areas of statistical genetics, in particular the development of powerful statistical approaches to analyse genetic data, as well as studying infectious diseases. Radhakrishnan, S. et al. (2020) “Rabies as a Public Health Concern in India-A Historical Perspective.”, Tropical medicine and infectious disease, 5(4), p. E162. Mateen, B. et al. (2020) “Improving the quality of machine learning in health applications and clinical research”, Nature Machine Intelligence, 2(10), pp. 554–556. Okell, L. et al. (2020) “Host or pathogen-related factors in COVID-19 severity? – Authors’ reply”, The Lancet, 396(10260), p. 1397. Pompe, E., Holmes, C. and Łatuszyński, K. (2020) “A framework for adaptive MCMC targeting multimodal distributions”, The Annals of Statistics, 48(5), pp. 2930–2952. Bitoun, E. et al. (2020) “ZCWPW1 is recruited to recombination hotspots by PRDM9, and is essential for meiotic double strand break repair”, eLife, 9. Charniga, K. et al. (2020) “Spatial and temporal invasion dynamics of the 2014-2017 Zika and chikungunya epidemics in Colombia”, p. 2020.09.11.20189811. Investigators:, R. et al. (2020) “Resurgence of SARS-CoV-2 in England: detection by community antigen surveillance”, p. 2020.09.11.20192492. Liu, X. et al. (2020) “Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension”, Lancet Digital Health, 2(10), pp. e537 - e548. Cruz Rivera, S. et al. (2020) “Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension”, Lancet Digital Health, 2(10), pp. e549 - e560. Sherrard-Smith, E. et al. (2020) “The potential public health consequences of COVID-19 on malaria in Africa.”, Nature medicine, 26(9), pp. 1411–1416. Previous page ‹‹ … Page 38 Page 39 Page 40 Page 41 Current page 42 Page 43 Page 44 Page 45 Page 46 … Next page ››